Why the study?
Can quantitative PCR assay be used to diagnose herpes simplex encephalitis and monitor response to antiviral therapy in children?
Can quantitative PCR assay be used to diagnose herpes simplex encephalitis and monitor response to antiviral therapy in children?
Quantitative PCR is useful for diagnosing herpes simplex encephalitis and monitoring the response to acyclovir therapy in children.
Neonates with HSV encephalitis may exhibit higher viral loads; this case report leaves open quantitative PCR utility for diagnosis and monitoring in children.
Herpes simplex virus (HSV) DNA in the cerebrospinal fluid (CSF) of children with herpes simplex encephalitis (HSE) was quantified and typed using the polymerase chain reaction (PCR) assay. During the acute phase, HSV-DNA was detected in the CSF of 13 patients with HSE, including 5 neonates. A restriction profile of the PCR products cleaved with the restriction enzymes XhoI and BglII showed that 2 neonatal samples were HSV-2, and the remainder were HSV-1. The amount of HSV-DNA in the initial CSF ranged from 10(2)-10(5) copies/ml. A significantly greater number of HSV-DNA copies was detected in neonates than in older children (mean 3.9 vs. 2.5, log 10 copies/ml p < .05). Except for one patient, the amount of HSV-DNA decreased gradually with acyclovir therapy. These results show that a quantitative PCR assay is applicable not only to the diagnosis of HSE but also for monitoring the response to antiviral drugs.
No takes yet. Share an insight, caveat, or question.
Kimura et al. (1993) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: